Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Neuropathic Pain in Multiple Sclerosis”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Large-scale testing (Phase 3)Study completedNCT00959218
What this trial is testing

Efficacy and Safety of the Pain Relieving Effect of Dronabinol in Central Neuropathic Pain Related to Multiple Sclerosis

Who this might be right for
Central Neuropathic Pain in Multiple Sclerosis
Bionorica Research GmbH 240
Large-scale testing (Phase 3)UnknownNCT06072001
What this trial is testing

Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis

Who this might be right for
PainPain SyndromePain, Chronic+10 more
Apurano Pharmaceuticals GmbH 558
Large-scale testing (Phase 3)Study completedNCT00755807
What this trial is testing

Duloxetine for Multiple Sclerosis Pain

Who this might be right for
Multiple Sclerosis
Eli Lilly and Company 239
Post-approval studies (Phase 4)Ended earlyNCT00414453
What this trial is testing

Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis

Who this might be right for
Neuropathic PainChronic PainMultiple Sclerosis
University of Rochester 19
Large-scale testing (Phase 3)Study completedNCT00391079
What this trial is testing

Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS

Who this might be right for
Multiple Sclerosis
GW Pharmaceuticals Ltd 339
Large-scale testing (Phase 3)UnknownNCT06071949
What this trial is testing

Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis

Who this might be right for
PainPain SyndromePain, Chronic+10 more
Apurano Pharmaceuticals GmbH 558
Large-scale testing (Phase 3)Study completedNCT01604265
What this trial is testing

Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis

Who this might be right for
Multiple SclerosisNeuropathic Pain
Jazz Pharmaceuticals 66
Testing effectiveness (Phase 2)Study completedNCT01324232
What this trial is testing

Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis

Who this might be right for
Central Neuropathic PainMultiple Sclerosis
Avanir Pharmaceuticals 209
Large-scale testing (Phase 3)UnknownNCT02059096
What this trial is testing

Analgesic Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) for Central Neuropathic Pain in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis With Central Neuropathic Pain
University Hospital, Clermont-Ferrand 66
Post-approval studies (Phase 4)Study completedNCT00480181
What this trial is testing

Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple Sclerosis

Who this might be right for
Neuropathic PainMultiple Sclerosis
University of Manitoba 50
Large-scale testing (Phase 3)Study completedNCT00291148
What this trial is testing

Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Management of MS-induced Neuropathic Pain

Who this might be right for
Neuropathic PainMultiple Sclerosis
University of Manitoba 75